Digital Technologies of Tomorrow QuickFire Challenge
Grant funding from a total of up to $100,000
Awardees
 |
求职者 Helpwear的目的是建立一个连续的临床ECG监测系统，能够提供近实时的数据来护理提供者，从而及时进行医疗干预措施，以防止房颤引起的隐性中风。 |
 |
US2.AI US2.AI旨在使用机器学习技术自动化对抗心脏病的斗争，以最高质量的超声心动图图像进行快速解释。 |
Overview
AI，IoT和3DP中的新兴技术可能会影响中国及其他地区的医疗保健未来。为了改善健康成果，进步的数字技术创新可能是中国2030年健康授权的核心。[1]Furthermore, the 2019 Future of Health Index identifies China as a ‘forerunner’ in adoption of new technologies in healthcare.[2]
释放健康技术的承诺可能是为最需要这些的患者带来变革性潜在突破的关键。
To that end, Johnson & Johnson Innovation together with Johnson & Johnson Medical Shanghai are proud to introduce the Digital Technologies of Tomorrow QuickFire Challenge. Visionaries are invited to submit novel, medical device ideaswith the potential to transform patient care in AFIB, neurovascular treatments, orthopedic and general surgery.
The innovator(s) with the best idea(s) will receive grant funding from a total of up to $100,000, one year of residency at JLABS @ Shanghai, and mentorship from experts of the Johnson & Johnson Family of Companies.
[1]https://www.who.int/healthpromotion/conferences/9gchp/healthy-china/en/
[2]https://www.philips.com/a-w/about/news/future-health-index/reports/2019/transforming-healthcare-experiences.html
兴趣范围
我们鼓励企业家和创新者的申请，目的是利用医疗设备技术，例如人工智能（AI），3D打印，物联网，5G，及以后的诊断，围手术期治疗解决方案以及新兴和变革性的技术，与特定有关：
- AFIB：我们如何利用数字技术来识别患者并将其推荐给适当的医生？我们如何追踪患者治疗后的缓解？
- 神经血管Treatments：我们如何检测早期治疗的迹象/中风风险？
- General and orthopedic surgery，，，，including distant operating stage support and AI-enabled procedure planning：如何使用新兴技术来推动更有效的潜在围手术期解决方案（包括术前，外科和手术后）？我们如何将创新的非传统材料应用于骨科手术？
Awards
- Residency at JLABS @ Shanghai including workstation and access to the JLABS ecosystem
- 约翰逊和约翰逊公司专家的指导。乐动体育意甲直播
Why this challenge matters to us
We believe a good idea can come from anywhere, and it’s our goal to find new and innovative technologies that aim to provide potential solutions to patients from around the world. Working together, we can spark the next great idea that could change the trajectory of health.
标准
提交者将根据审阅者和法官的符合以下标准的能力进行评估：
- Problem space and potential impact
- 能够超越当前解决方案的立即影响
- 当前市场的潜在解决方案和竞争水平的独特性
- 质量& feasibility of the potential solution to commercialize within 12 months
- Team credibility & capabilities
- Clarity of plan: milestones & defined go/no
- 对中国生态系统的潜在影响
常见问题解答
如果我在访问门户网站时遇到麻烦怎么办？
Make sure your browser is up to date and accepting cookies.
Can I submit supporting documents (for example a video) as part of my application?
您将有机会，并鼓励您上传支持材料，例如幻灯片，研究论文和视频，作为您应用程序的一部分。您可以提交视频以及打字的响应。最大长度为两分钟。
Is it ok if some of the information I submit is confidential?
不要提交机密信息。仅应提交非固定信息，并且您提交的任何内容都将被视为非机密。
What happens with IP (Intellectual Property)?
As this is a no-strings-attached arrangement, JLABS does not acquire any IP. Any IP creation and/or protection remains the sole responsibility of the inventors.
是否需要申请专利？
No, a patent is not required to apply. However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.
What kind of science / technology is appropriate for the Challenges?
We encourage applications from entrepreneurs & innovators working with the aim to harness medical device technologies such as Artificial Intelligence (AI), 3D-printing, IoT, 5G, and beyond in treatment pathways, diagnostics, emerging and transformative technologies, related specifically to:
- AFIB
- 神经血管
- General and orthopedic surgery，，，，including distant operating stage support and AI-enabled procedure planning
Who is eligible to apply?
Each Challenge has its own terms & conditions that can be found prior to filling out the application.
申请人是否必须居住在中国才能申请？
No, this is a global challenge.
如果我对挑战或申请过程有疑问，我可以联系谁？
请联系[email protected]with any questions.
我在哪里申请？我必须一次坐下来完成申请吗？
请访问https://jnjquickfire.secure-platform.com了解更多信息。从那里，您将被指示设置一个帐户。您可以保存工作并登录，以便在需要时在以后的时间完成。
Timeline
About Johnson & Johnson Innovation
强生公司创新,公司专注于accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation – JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit:www.jnjinnovation.com.
关于Johnson＆Johnson Innovation -Jlabs
Johnson & Johnson Innovation-JLABS（JLABS）是一个全球开放创新生态系统的网络，在广泛的医疗保健范围内促进并赋予创新者，包括药品，医疗设备，消费者和健康技术领域，以创建和加速生命，生命增强，生命增强健康，健康和保健的健康，保健和保健，保健和保健，保健和保健健康，保健和保健技术领域。对世界各地患者的解决方案。JLABS通过为新兴公司提供最佳环境来实现这一点明天的突破性医疗解决方案。在JLABS，我们重视伟大的想法，并热衷于消除成功的障碍，以帮助创新者释放其早期科学发现的潜力。JLABS是一个无弦的模型，这意味着企业家可以在坚持其知识产权的同时自由发展科学。JLABS还发表了运动，以寻找名为Quickfire挑战的最佳科学。乐动体育为什么赞助西甲有关更多信息，请访问www.www.2574design.comor follow@JLABS。
强生公司
强生是全球业务分布广泛、综合性的跨国医疗保健企业，业务涉及消费品、制药、医疗器材三大领域，1985年在华创立了第一家合资企业。强生遵循企业信条的价值观，致力于践行“关爱全世界,关注每个人”的健康愿景，以领先的科技研发创造创新的理念、产品和服务，为改善人类健康和福祉而不懈努力。每天，强生遍布世界各地的员工，与他们的合作方一起，为全球消费者和病患带来更健康、更快乐、更长寿的生活。